AURELION INC (AURE) Fundamental Analysis & Valuation

NASDAQ:AURE • KYG7244A1278

Current stock price

2.5 USD
+0.06 (+2.46%)
Last:

This AURE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. AURE Profitability Analysis

1.1 Basic Checks

  • AURE had negative earnings in the past year.
  • In multiple years AURE reported negative net income over the last 5 years.
  • In multiple years AURE reported negative operating cash flow during the last 5 years.
AURE Yearly Net Income VS EBIT VS OCF VS FCFAURE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 2M -2M -4M -6M

1.2 Ratios

  • The Return On Assets of AURE (-55.14%) is worse than 93.72% of its industry peers.
  • AURE's Return On Equity of -62.76% is on the low side compared to the rest of the industry. AURE is outperformed by 86.61% of its industry peers.
Industry RankSector Rank
ROA -55.14%
ROE -62.76%
ROIC N/A
ROA(3y)-33.76%
ROA(5y)-6.58%
ROE(3y)-72.6%
ROE(5y)-27.63%
ROIC(3y)N/A
ROIC(5y)N/A
AURE Yearly ROA, ROE, ROICAURE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for AURE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AURE Yearly Profit, Operating, Gross MarginsAURE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

5

2. AURE Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for AURE has been increased compared to 1 year ago.
  • The number of shares outstanding for AURE has been increased compared to 5 years ago.
  • AURE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
AURE Yearly Shares OutstandingAURE Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 500K 1M
AURE Yearly Total Debt VS Total AssetsAURE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

2.2 Solvency

  • An Altman-Z score of 21.09 indicates that AURE is not in any danger for bankruptcy at the moment.
  • AURE has a Altman-Z score of 21.09. This is amongst the best in the industry. AURE outperforms 97.49% of its industry peers.
  • There is no outstanding debt for AURE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 21.09
ROIC/WACCN/A
WACCN/A
AURE Yearly LT Debt VS Equity VS FCFAURE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 2M 4M 6M

2.3 Liquidity

  • A Current Ratio of 0.19 indicates that AURE may have some problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 0.19, AURE is doing worse than 88.70% of the companies in the same industry.
  • AURE has a Quick Ratio of 0.19. This is a bad value and indicates that AURE is not financially healthy enough and could expect problems in meeting its short term obligations.
  • AURE has a worse Quick ratio (0.19) than 88.70% of its industry peers.
Industry RankSector Rank
Current Ratio 0.19
Quick Ratio 0.19
AURE Yearly Current Assets VS Current LiabilitesAURE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

0

3. AURE Growth Analysis

3.1 Past

  • The earnings per share for AURE have decreased strongly by -210.59% in the last year.
  • Looking at the last year, AURE shows a very negative growth in Revenue. The Revenue has decreased by -49.22% in the last year.
  • The Revenue for AURE have been decreasing by -22.64% on average. This is quite bad
EPS 1Y (TTM)-210.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-130.33%
Revenue 1Y (TTM)-49.22%
Revenue growth 3Y-38.79%
Revenue growth 5Y-22.64%
Sales Q2Q%-99.94%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AURE Yearly Revenue VS EstimatesAURE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M

0

4. AURE Valuation Analysis

4.1 Price/Earnings Ratio

  • AURE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AURE Price Earnings VS Forward Price EarningsAURE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AURE Per share dataAURE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4 -6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. AURE Dividend Analysis

5.1 Amount

  • AURE does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

AURE Fundamentals: All Metrics, Ratios and Statistics

AURELION INC

NASDAQ:AURE (4/24/2026, 8:22:10 PM)

2.5

+0.06 (+2.46%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners14.68%
Inst Owner ChangeN/A
Ins Owners0.46%
Ins Owner Change0%
Market Cap86.53M
Revenue(TTM)142.60K
Net Income(TTM)-10.01M
AnalystsN/A
Price TargetN/A
Short Float %0.58%
Short Ratio0.51
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 606.77
P/FCF N/A
P/OCF N/A
P/B 5.43
P/tB 49.11
EV/EBITDA N/A
EPS(TTM)-6.96
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS0.46
TBVpS0.05
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -55.14%
ROE -62.76%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-33.76%
ROA(5y)-6.58%
ROE(3y)-72.6%
ROE(5y)-27.63%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.19
Quick Ratio 0.19
Altman-Z 21.09
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-210.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-130.33%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-49.22%
Revenue growth 3Y-38.79%
Revenue growth 5Y-22.64%
Sales Q2Q%-99.94%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-413.78%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-66.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-66.08%
OCF growth 3YN/A
OCF growth 5YN/A

AURELION INC / AURE Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for AURELION INC?

ChartMill assigns a fundamental rating of 2 / 10 to AURE.


Can you provide the valuation status for AURELION INC?

ChartMill assigns a valuation rating of 0 / 10 to AURELION INC (AURE). This can be considered as Overvalued.


Can you provide the profitability details for AURELION INC?

AURELION INC (AURE) has a profitability rating of 1 / 10.


How financially healthy is AURELION INC?

The financial health rating of AURELION INC (AURE) is 5 / 10.